TrumpRx: Trump And HHS To Offer Weight Loss GLP-1 Drugs Ozempic And Wegovy At Cheaper Prices To Tackle Obesity Crisis, As Healthy Eating Goes Out The Window

By The WinePress

Yesterday, the Trump administration announced its latest drug deal by offering GLP-1 weight loss drugs Ozempic, Regovy and others, at significantly reduced prices via the administration’s direct-to-consumer program TrumpRx for Medicare recipients.

As previously reported, Trump signed an executive order that aimed to perceivably strongarm pharmaceutical and biotech companies to lower prices while investing in infrastructure domestically to avoid paying tariffs. The White House sent a letter to these many drug companies to comply. In September, Pfizer became the first company to work directly with the administration to offer cheaper drug costs; though, as was pointed out at the time, federal filings revealed that Pfizer (and probably other companies) were preparing to launch a direct-to-consumer model to cut out the middleman, thus implying that perhaps Pfizer (and probably other companies) approached the administration with this idea, and the administration will skim off the top by putting Trump’s name on it…

READ FULL ARTICLE HERE… (thewinepress.substack.com)

 

---

Home | Caravan to Midnight (zutalk.com)

We Need Your Help To Keep Caravan To Midnight Going,

Please Consider Donating To Help Keep Independent Media Independent